Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL

The HDL Atherosclerosis Treatment Study (HATS) demonstrated a clinical benefit in coronary artery disease patients with low HDL cholesterol (HDL-C) levels treated with simvastatin and niacin (S-N) or S-N plus antioxidants (S-N+A) compared with antioxidants alone or placebo. Angiographically document...

Full description

Bibliographic Details
Main Authors: Nirupa R. Matthan, Ann Giovanni, Ernst J. Schaefer, B.Greg Brown, Alice H. Lichtenstein
Format: Article
Language:English
Published: Elsevier 2003-04-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520311706